PREZIOSA, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 5.750
EU - Europa 5.381
NA - Nord America 4.081
SA - Sud America 1.151
AF - Africa 144
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.527
Nazione #
US - Stati Uniti d'America 3.874
RU - Federazione Russa 3.251
SG - Singapore 2.134
CN - Cina 1.734
BR - Brasile 914
HK - Hong Kong 750
IT - Italia 622
VN - Vietnam 485
SE - Svezia 358
FR - Francia 300
DE - Germania 275
GB - Regno Unito 158
IN - India 122
BD - Bangladesh 105
FI - Finlandia 99
AR - Argentina 97
CA - Canada 81
MX - Messico 80
IR - Iran 59
NL - Olanda 55
TR - Turchia 55
PL - Polonia 52
ZA - Sudafrica 48
ES - Italia 45
JP - Giappone 45
EC - Ecuador 44
IQ - Iraq 42
AT - Austria 41
ID - Indonesia 33
SA - Arabia Saudita 33
CO - Colombia 27
IE - Irlanda 25
EG - Egitto 23
MA - Marocco 21
VE - Venezuela 21
LT - Lituania 18
KE - Kenya 16
PK - Pakistan 16
PT - Portogallo 16
BE - Belgio 15
MY - Malesia 15
PY - Paraguay 15
AE - Emirati Arabi Uniti 14
CL - Cile 14
UZ - Uzbekistan 14
AU - Australia 13
IL - Israele 12
TN - Tunisia 12
UA - Ucraina 11
CH - Svizzera 10
PE - Perù 10
JM - Giamaica 9
HN - Honduras 8
NP - Nepal 8
JO - Giordania 7
LB - Libano 7
MD - Moldavia 7
AZ - Azerbaigian 6
CR - Costa Rica 6
CY - Cipro 6
KR - Corea 6
NO - Norvegia 6
TW - Taiwan 6
UY - Uruguay 6
AO - Angola 5
KZ - Kazakistan 5
NG - Nigeria 5
PA - Panama 5
TH - Thailandia 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
BH - Bahrain 3
CI - Costa d'Avorio 3
GR - Grecia 3
KH - Cambogia 3
OM - Oman 3
PH - Filippine 3
PS - Palestinian Territory 3
RO - Romania 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GA - Gabon 2
GT - Guatemala 2
NI - Nicaragua 2
PR - Porto Rico 2
QA - Qatar 2
BF - Burkina Faso 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
DM - Dominica 1
GD - Grenada 1
Totale 16.514
Città #
Singapore 1.006
Dallas 974
Hong Kong 726
Moscow 723
San Jose 533
Ashburn 512
Beijing 268
Hefei 251
Shanghai 222
Lauterbourg 220
Ho Chi Minh City 181
New York 163
Milan 157
Hanoi 115
Los Angeles 115
Princeton 97
Lawrence 96
São Paulo 91
Munich 88
Boardman 69
Rome 59
Santa Clara 57
Helsinki 56
Orem 51
Nuremberg 47
Council Bluffs 41
Mexico City 41
Chennai 39
Guangzhou 38
Frankfurt am Main 37
Rio de Janeiro 37
Denver 36
Warsaw 35
Tokyo 34
Poplar 28
Houston 27
Brooklyn 26
Johannesburg 26
Montreal 26
Chicago 25
Boston 24
Cesano Boscone 24
Da Nang 24
Dublin 24
London 24
Stockholm 24
Ankara 23
Phoenix 23
The Dalles 23
Turku 23
Atlanta 22
Haiphong 22
Shenzhen 22
Belo Horizonte 21
Manchester 21
Tianjin 21
Tehran 20
Baghdad 19
Amsterdam 18
Curitiba 18
Lappeenranta 18
Istanbul 17
Vienna 17
Brasília 16
Mumbai 16
New Delhi 15
Radebeul 15
Toronto 15
Washington 15
Guayaquil 14
Hangzhou 14
Philadelphia 14
Cairo 13
Charlotte 13
Naples 13
Quito 13
Biên Hòa 12
Riyadh 12
Seattle 12
Brussels 11
Buffalo 11
Campinas 11
Nairobi 11
Paris 11
Buenos Aires 10
Columbus 10
Dhaka 10
Erbil 10
Genoa 10
Madrid 10
Medellín 10
Palermo 10
Pittsburgh 10
Porto Alegre 10
Siena 10
Tashkent 10
Asunción 9
Falkenstein 9
Hải Dương 9
Jeddah 9
Totale 8.298
Nome #
Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4) 364
A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging 162
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability 159
Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study 158
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 157
Impact of Multiple Sclerosis on Cognitive Aging: A Multicenter Study 156
Dynamic functional connectivity of thalamic sub-regions shows divegent patterns in multiple sclerosis phenotypes 146
Gray matter damage predicts the accumulation of disability 13 years later in MS. 140
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 134
Voxel-wise multimodal MRI reveals specific patterns of brain damage in the main multiple sclerosis phenotypes 126
Tolebrutinib for non-relapsing secondary progressive multiple sclerosis: a critical therapeutic gap 123
Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes in multiple sclerosis 123
Cognitive Reserve Modulates the Impact of Structural Damage of the Frontal Lobe on Executive Functioning in Multiple Sclerosis (P1-1.Virtual) 123
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex 121
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 118
Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study 117
Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis 116
Chronic Active Lesions and Larger Choroid Plexus Explain Cognition and Fatigue in Multiple Sclerosis 112
Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis 112
Resting State Functional Connectivity Correlates of Executive Function in Patients with Multiple Sclerosis 110
In vivo detection of damage in multiple sclerosis cortex and cortical lesions using NODDI 109
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial 107
Monoaminergic network abnormalities: a marker for multiple sclerosis-related fatigue and depression 106
Functional and structural MRI correlates of executive functions in multiple sclerosis 106
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics 105
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis 102
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis 98
A semiautomatic method for multiple sclerosis lesion segmentation on dual-echo MR imaging: application in a multicenter context 98
Diagnosis of Progressive Multiple Sclerosis from the Imaging Perspective: A Review 97
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis 94
Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex 94
Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer's disease 94
Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients 93
Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series 93
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus 93
Resting state functional connectivity modifications in monoaminergic circuits underpin fatigue development in patients with multiple sclerosis 92
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines 92
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives 92
Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives 91
Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study 90
Advances in neuroimaging of multiple sclerosis 90
Subventricular Zone Microstructure in Pediatric-Onset Multiple Sclerosis 90
Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis 89
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 88
Action observation training modifies brain gray matter structure in healthy adult individuals 88
Action observation training promotes motor improvement and modulates functional network dynamic connectivity in multiple sclerosis 88
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis 87
Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19? 86
Brain and cervical spinal cord MRI correlates of sensorimotor impairment in patients with multiple sclerosis 85
Aerobic capacity moderates the association between cervical cord atrophy and clinical disability in mildly disabled multiple sclerosis patients 85
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 85
Association between pathological and MRI findings in multiple sclerosis 84
Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression 84
Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis 83
A demyelinating disorder characterized by repeated episodes of optic neuritis and brainstem dysfuntions in a girl with anti-MOG positivity 83
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study 83
Clinical relevance of spatial correspondence between regional gene expression and grey matter atrophy in multiple sclerosis 82
Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability 82
Cervical spinal cord gray matter damage predicts disability worsening in multiple sclerosis: a longitudinal study 81
Dynamics of choroid plexus volume is associated with the presence and development of fatigue in multiple sclerosis 81
Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis 81
Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex 81
Spinal Cord Abnormalities in Early Pediatric Multiple Sclerosis 79
Human functional MRI 79
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study 78
Paramagnetic rim lesion burden and choroid plexus enlargement contribute to cognitive impairment and fatigue in multiple sclerosis 78
Divergent time-varying connectivity of thalamic sub-regions characterizes clinical phenotypes and cognitive status in multiple sclerosis 78
Choroid plexus and perivascular spaces enlargement in neuropsychiatric systemic lupus erythematosus 77
Correction to: Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders (Journal of Neurology, (2024), 271, 7, (3879-3896), 10.1007/s00415-024-12426-w) 77
Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis 77
Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family 76
Assessment of central vein sign and paramagnetic rim lesions in pediatric multiple sclerosis 75
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study 75
Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein–immunoglobulin G-associated Disease 75
Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study 75
What role should spinal cord MRI take in the future of multiple sclerosis surveillance? 75
Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders 75
Correspondence between gray matter atrophy and neurotransmitter maps is relevant in multiple sclerosis 74
Artificial Intelligence Applied on Conventional Magnetic Resonance Images Improves the Correct Diagnosis of CNS Diseases Mimicking Multiple Sclerosis 74
Application of DIR and DT MRI to quantify focal and diffuse cortical damage in MS. 73
Can post-mortem MRI be used as a proxy for in vivo? A case study 72
Artificial intelligence applied on conventional magnetic resonance images improves the correct diagnosis of CNS diseases mimicking multiple sclerosis 72
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication 72
Radiologically isolated syndromes: to treat or not to treat? 71
The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis 71
Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR Study 71
Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosis 71
Randomized controlled trials for multiple sclerosis: integrating pathology-driven outcomes to capture therapeutic efficacy 70
Information from ecological momentary assessments leads to over-medicalization: No 69
Quantitative MRI adds to neuropsychiatric lupus diagnostics 69
MRI of Transcallosal White Matter Helps to Predict Motor Impairment in Multiple Sclerosis 69
Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study 68
Different CSF-in gradients of damage occur in the thalamus, caudate nucleus and cortex in multiple sclerosis: a 3T magnetization transfer ratio and R2*study 67
Clinical relevance of multiparametric MRI assessment of spinal cord damage in multiple sclerosis 67
Age Matters in Multiple Sclerosis: Novel Insights Into Disease Progression From Clinical Onset 67
Central vein sign and iron rim in multiple sclerosis: ready for clinical use? 67
Sex-related differences in upper limb motor function in healthy subjects and multiple sclerosis patients: a multiparametric MRI study 67
Use of brain MRI and gene expression atlases to reconstruct the pathophysiology of autoimmune neurological disorders: The proof-of-concept of NMOSD 66
Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment 66
Clinically isolated syndromes suggestive of multiple sclerosis: dynamic patterns of gray and white matter changes - a 2 year MR imaging study 66
Totale 9.437
Categoria #
all - tutte 83.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.553


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/2022130 1 4 5 40 2 10 11 19 15 7 9 7
2022/2023737 225 116 57 8 21 79 25 42 66 31 20 47
2023/2024725 32 46 52 111 65 81 59 68 9 53 49 100
2024/20253.468 250 97 102 85 124 183 256 357 688 568 287 471
2025/202611.933 914 948 1.052 1.599 834 313 989 849 3.008 801 401 225
Totale 17.102